U.S. markets open in 5 hours 17 minutes

CCM Duopharma Biotech Berhad (7148.KL)

Kuala Lumpur - Kuala Lumpur Delayed Price. Currency in MYR
Add to watchlist
2.8500-0.0300 (-1.04%)
At close: 4:58PM MYT
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Breakdown
ttm
12/31/2019
12/31/2018
12/31/2017
Total Revenue
554,341
576,462
498,722
467,987
Cost of Revenue
324,574
344,395
294,242
281,100
Gross Profit
229,767
232,067
204,480
186,887
Operating Expense
147,023
155,352
140,279
133,064
Operating Income
82,744
76,715
64,201
53,823
Net Non Operating Interest Income Expense
-8,216
-6,836
-5,618
-2,551
Pretax Income
74,528
70,809
59,666
51,772
Tax Provision
15,175
15,536
12,025
9,309
Net Income Common Stockholders
57,609
55,273
47,641
42,463
Diluted NI Available to Com Stockholders
57,609
55,273
47,641
42,463
Basic EPS
-
0
0
0
Diluted EPS
-
0
0
0
Basic Average Shares
-
670,221
655,925
650,904
Diluted Average Shares
-
670,221
655,925
650,904
Total Operating Income as Reported
82,744
77,645
65,284
54,323
Rent Expense Supplemental
-
0
3,385
-
Total Expenses
471,597
499,747
434,521
414,164
Net Income from Continuing & Discontinued Operation
57,609
55,273
47,641
42,463
Normalized Income
57,609
54,951
47,641
42,463
Interest Income
1,832
1,463
2,111
2,718
Interest Expense
9,830
7,960
7,554
4,995
Net Interest Income
-8,216
-6,836
-5,618
-2,551
EBIT
84,358
78,769
67,220
56,767
EBITDA
109,709
-
-
-
Reconciled Cost of Revenue
324,574
344,395
294,242
281,100
Reconciled Depreciation
25,351
26,854
24,726
24,120
Net Income from Continuing Operation Net Minority Interest
54,450
55,273
47,641
42,463
Total Unusual Items Excluding Goodwill
-
412
-
-
Total Unusual Items
-
412
-
-
Normalized EBITDA
109,709
105,211
91,946
80,887
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0
90.3957
0
0